Allison David D. 4/A
4/A · CinCor Pharma, Inc. · Filed Jul 20, 2022
Insider Transaction Report
Form 4/AAmended
Allison David D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-08$12.04/sh+1,038$12,498→ 1,038 totalExercise: $19.55From: 2022-04-08Exp: 2032-04-07→ Common Stock (1,038 underlying)
Footnotes (2)
- [F1]This option was issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of retainer fees of $12,500.
- [F2]This amendment to the Form 4 initially filed on May 11, 2022 is being made to clarify the purpose of the option grant set forth in footnote 1 above and the amount in director retainer fees foregone as set forth in box 8 above.